Moderna COVID-19 vaccine (also known as Spikevax) overview and safety

Details

• Alternative Title:
  Information about the Moderna COVID-19 Vaccine
• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated June 19, 2022 ; Recommended for People 18 Years and Older and Children Ages 6 months to 5 Years ; Primary Series: ; • 18 years and older: 2 doses of Moderna in the primary series, given 4–8 weeks apart. People who are moderately or severely immunocompromised (have a weakened immune system) should get a 3rd dose at least 4 weeks after their 2nd dose in the primary series. ; • 6 months through 5 years: 2 doses of Moderna in the primary series, given 4-8 weeks apart. For people who are moderately or severely immunocompromised (have a weakened immune system), the first and second doses are separated by four weeks, and the second and third doses are separated by at least four weeks. ; Boosters: ; • 18 years and older: People who received a Moderna primary series should get a booster. Only some people can get a 2nd booster dose. Use CDC’s COVID-19 booster tool to learn if and when you can get boosters to stay up to date with your COVID-19 vaccines. ; • 6 months through 5 years: Currently a booster dose is not authorized for children in this age group who received a Moderna primary series.
• Subjects:
  • 2019-nCoV Vaccine mRNA-1273
  • Coronavirus Infections/prevention & control
  • COVID-19 Vaccines
  • COVID-19/prevention & control
  • Viral Vaccines
• Document Type:
  Webpage
• Corporate as Subject:
  Moderna COVID-19 vaccine ; Spikevax
• Download URL:
  https://stacks.cdc.gov/view/cdc/118404/cdc_118404_DS1.pdf
• File Type:
  [PDF - 394.78 KB]
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:c9896163200a44c2af945fed64852b5a755f087d1d3aed744f4c16c3686d5cf7